Anadys gets Fda Ok to start hepatitis C study

Full story: IBJ.COM

Anadys Pharmaceuticals Inc. said Thursday the Food and Drug Administration cleared the company's plan for a midstage study on a potential combination therapy for hepatitis C. The combination includes the drug candidate ANA598, with Interferon-Alpha and Ribavirin.

Post

Leave a Comment

Email me Hepatitis news. Learn more

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Hepatitis Discussions

Topic	Updated	Last By	Comments
Marin AIDS Project to celebrate anniversary	Mon	Jess	1
Hepatitis lawsuit filed against McDonald's (Aug '09)	Feb 7	Pulipaca	13
Vitiligo treatment	Feb 3	dreeman	1
This is interesting reading! "Is Angelina Jolie... (Aug '07)	Feb 1	Nic	14
Let's talk about the hazards of lesbian sex (Jan '09)	Jan 25	flyboy	71
Dancin' in the rain	Jan 22	Monkey Boy	1
Ga. congressman to run again, depite hepatitis C	Jan 18	For Justice	15